The power of phase II end-points for different possible mechanisms of action of an experimental treatment
about
The European Organization for Research and Treatment of Cancer perspective on designing clinical trials with immune therapeuticsStatistical controversies in clinical research: should schedules of tumor size assessments be changed?Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis.
P2860
The power of phase II end-points for different possible mechanisms of action of an experimental treatment
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The power of phase II end-poin ...... n of an experimental treatment
@ast
The power of phase II end-poin ...... n of an experimental treatment
@en
type
label
The power of phase II end-poin ...... n of an experimental treatment
@ast
The power of phase II end-poin ...... n of an experimental treatment
@en
prefLabel
The power of phase II end-poin ...... n of an experimental treatment
@ast
The power of phase II end-poin ...... n of an experimental treatment
@en
P2860
P1476
The power of phase II end-poin ...... n of an experimental treatment
@en
P2093
A Dentamaro
P2860
P304
P356
10.1016/J.EJCA.2015.03.002
P50
P577
2015-03-31T00:00:00Z